6.91 USD
+0.03 (+0.44%)
6.91 USD
0 (0%)
We assign a fundamental rating of 6 out of 10 to VMD. VMD was compared to 101 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of VMD get a neutral evaluation. Nothing too spectacular is happening here. VMD is not overvalued while it is showing excellent growth. This is an interesting combination. This makes VMD very considerable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year VMD was profitable.
VMD had a positive operating cash flow in the past year.
VMD had positive earnings in each of the past 5 years.
VMD had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of VMD (6.73%) is better than 88.12% of its industry peers.
VMD has a better Return On Equity (10.19%) than 73.27% of its industry peers.
The Return On Invested Capital of VMD (7.79%) is better than 74.26% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for VMD is in line with the industry average of 9.26%.
The 3 year average ROIC (7.66%) for VMD is below the current ROIC(7.79%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.73% | ||
| ROE | 10.19% | ||
| ROIC | 7.8% |
ROA(3y)6.09%
ROA(5y)10.79%
ROE(3y)7.98%
ROE(5y)14.42%
ROIC(3y)7.66%
ROIC(5y)10.17%
1.3 Margins
VMD's Profit Margin of 5.34% is fine compared to the rest of the industry. VMD outperforms 79.21% of its industry peers.
VMD's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 6.83%, VMD is in the better half of the industry, outperforming 69.31% of the companies in the same industry.
VMD's Operating Margin has declined in the last couple of years.
The Gross Margin of VMD (57.89%) is better than 79.21% of its industry peers.
VMD's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.83% | ||
| PM (TTM) | 5.34% | ||
| GM | 57.89% |
OM growth 3Y-11.38%
OM growth 5Y-8.84%
PM growth 3Y-13.54%
PM growth 5Y-13.85%
GM growth 3Y-1.78%
GM growth 5Y-3.16%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so VMD is destroying value.
Compared to 1 year ago, VMD has more shares outstanding
The number of shares outstanding for VMD has been increased compared to 5 years ago.
VMD has a better debt/assets ratio than last year.
2.2 Solvency
VMD has an Altman-Z score of 4.58. This indicates that VMD is financially healthy and has little risk of bankruptcy at the moment.
VMD has a better Altman-Z score (4.58) than 81.19% of its industry peers.
VMD has a debt to FCF ratio of 3.93. This is a good value and a sign of high solvency as VMD would need 3.93 years to pay back of all of its debts.
VMD's Debt to FCF ratio of 3.93 is fine compared to the rest of the industry. VMD outperforms 72.28% of its industry peers.
A Debt/Equity ratio of 0.15 indicates that VMD is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.15, VMD is doing good in the industry, outperforming 72.28% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 3.93 | ||
| Altman-Z | 4.58 |
ROIC/WACC0.87
WACC8.92%
2.3 Liquidity
A Current Ratio of 1.13 indicates that VMD should not have too much problems paying its short term obligations.
The Current ratio of VMD (1.13) is worse than 61.39% of its industry peers.
A Quick Ratio of 1.01 indicates that VMD should not have too much problems paying its short term obligations.
VMD has a Quick ratio of 1.01. This is in the lower half of the industry: VMD underperforms 67.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.13 | ||
| Quick Ratio | 1.01 |
3. Growth
3.1 Past
VMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.22%, which is quite impressive.
Measured over the past 5 years, VMD shows a small growth in Earnings Per Share. The EPS has been growing by 4.01% on average per year.
The Revenue has grown by 18.90% in the past year. This is quite good.
VMD shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 22.80% yearly.
EPS 1Y (TTM)22.22%
EPS 3Y8.37%
EPS 5Y4.01%
EPS Q2Q%-10%
Revenue 1Y (TTM)18.9%
Revenue growth 3Y24.18%
Revenue growth 5Y22.8%
Sales Q2Q%23.98%
3.2 Future
VMD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.89% yearly.
VMD is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.73% yearly.
EPS Next Y31.06%
EPS Next 2Y32.27%
EPS Next 3Y24.89%
EPS Next 5YN/A
Revenue Next Year18.33%
Revenue Next 2Y17.92%
Revenue Next 3Y17.73%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 20.94, VMD is valued on the expensive side.
Compared to the rest of the industry, the Price/Earnings ratio of VMD indicates a somewhat cheap valuation: VMD is cheaper than 67.33% of the companies listed in the same industry.
VMD's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.31.
A Price/Forward Earnings ratio of 14.11 indicates a correct valuation of VMD.
Based on the Price/Forward Earnings ratio, VMD is valued cheaper than 80.20% of the companies in the same industry.
VMD is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.59, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.94 | ||
| Fwd PE | 14.11 |
4.2 Price Multiples
90.10% of the companies in the same industry are more expensive than VMD, based on the Enterprise Value to EBITDA ratio.
VMD's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 49.78 | ||
| EV/EBITDA | 6.18 |
4.3 Compensation for Growth
VMD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
VMD has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as VMD's earnings are expected to grow with 24.89% in the coming years.
PEG (NY)0.67
PEG (5Y)5.22
EPS Next 2Y32.27%
EPS Next 3Y24.89%
5. Dividend
5.1 Amount
No dividends for VMD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
6.91
+0.03 (+0.44%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners68.04%
Inst Owner ChangeN/A
Ins Owners13.25%
Ins Owner Change1%
Market Cap268.04M
Revenue(TTM)254.79M
Net Income(TTM)13.61M
Analysts80
Price Target13.26 (91.9%)
Short Float %1.17%
Short Ratio2.35
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.99%
Min EPS beat(2)-0.99%
Max EPS beat(2)-0.99%
EPS beat(4)0
Avg EPS beat(4)-2.17%
Min EPS beat(4)-5.7%
Max EPS beat(4)-0.99%
EPS beat(8)1
Avg EPS beat(8)-9.3%
EPS beat(12)3
Avg EPS beat(12)-5.6%
EPS beat(16)4
Avg EPS beat(16)-6.65%
Revenue beat(2)0
Avg Revenue beat(2)-1.08%
Min Revenue beat(2)-1.11%
Max Revenue beat(2)-1.06%
Revenue beat(4)1
Avg Revenue beat(4)-1.33%
Min Revenue beat(4)-3.39%
Max Revenue beat(4)0.24%
Revenue beat(8)5
Avg Revenue beat(8)-0.38%
Revenue beat(12)7
Avg Revenue beat(12)-0.14%
Revenue beat(16)11
Avg Revenue beat(16)0.61%
PT rev (1m)-4.88%
PT rev (3m)-4.88%
EPS NQ rev (1m)8.33%
EPS NQ rev (3m)8.33%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)3.12%
Revenue NQ rev (3m)3.12%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.94 | ||
| Fwd PE | 14.11 | ||
| P/S | 1.05 | ||
| P/FCF | 49.78 | ||
| P/OCF | 5.53 | ||
| P/B | 2.01 | ||
| P/tB | 3.63 | ||
| EV/EBITDA | 6.18 |
EPS(TTM)0.33
EY4.78%
EPS(NY)0.49
Fwd EY7.09%
FCF(TTM)0.14
FCFY2.01%
OCF(TTM)1.25
OCFY18.08%
SpS6.57
BVpS3.44
TBVpS1.9
PEG (NY)0.67
PEG (5Y)5.22
Graham Number5.06
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.73% | ||
| ROE | 10.19% | ||
| ROCE | 11% | ||
| ROIC | 7.8% | ||
| ROICexc | 8.38% | ||
| ROICexgc | 14.13% | ||
| OM | 6.83% | ||
| PM (TTM) | 5.34% | ||
| GM | 57.89% | ||
| FCFM | 2.11% |
ROA(3y)6.09%
ROA(5y)10.79%
ROE(3y)7.98%
ROE(5y)14.42%
ROIC(3y)7.66%
ROIC(5y)10.17%
ROICexc(3y)8.81%
ROICexc(5y)13.58%
ROICexgc(3y)11.22%
ROICexgc(5y)15.03%
ROCE(3y)10.8%
ROCE(5y)14.35%
ROICexgc growth 3Y2.65%
ROICexgc growth 5Y-2.94%
ROICexc growth 3Y-7.87%
ROICexc growth 5Y-9.04%
OM growth 3Y-11.38%
OM growth 5Y-8.84%
PM growth 3Y-13.54%
PM growth 5Y-13.85%
GM growth 3Y-1.78%
GM growth 5Y-3.16%
F-Score5
Asset Turnover1.26
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 3.93 | ||
| Debt/EBITDA | 0.44 | ||
| Cap/Depr | 157.16% | ||
| Cap/Sales | 16.91% | ||
| Interest Coverage | 21.97 | ||
| Cash Conversion | 108.16% | ||
| Profit Quality | 39.56% | ||
| Current Ratio | 1.13 | ||
| Quick Ratio | 1.01 | ||
| Altman-Z | 4.58 |
F-Score5
WACC8.92%
ROIC/WACC0.87
Cap/Depr(3y)138.25%
Cap/Depr(5y)145.08%
Cap/Sales(3y)15.87%
Cap/Sales(5y)14.88%
Profit Quality(3y)92.19%
Profit Quality(5y)75.37%
High Growth Momentum
Growth
EPS 1Y (TTM)22.22%
EPS 3Y8.37%
EPS 5Y4.01%
EPS Q2Q%-10%
EPS Next Y31.06%
EPS Next 2Y32.27%
EPS Next 3Y24.89%
EPS Next 5YN/A
Revenue 1Y (TTM)18.9%
Revenue growth 3Y24.18%
Revenue growth 5Y22.8%
Sales Q2Q%23.98%
Revenue Next Year18.33%
Revenue Next 2Y17.92%
Revenue Next 3Y17.73%
Revenue Next 5YN/A
EBIT growth 1Y7.34%
EBIT growth 3Y10.05%
EBIT growth 5Y11.94%
EBIT Next Year219.91%
EBIT Next 3Y63.61%
EBIT Next 5YN/A
FCF growth 1Y-66.11%
FCF growth 3Y-21.74%
FCF growth 5Y-25.39%
OCF growth 1Y22.32%
OCF growth 3Y20.23%
OCF growth 5Y15.41%
VIEMED HEALTHCARE INC / VMD FAQ
What is the ChartMill fundamental rating of VIEMED HEALTHCARE INC (VMD) stock?
ChartMill assigns a fundamental rating of 6 / 10 to VMD.
What is the valuation status for VMD stock?
ChartMill assigns a valuation rating of 6 / 10 to VIEMED HEALTHCARE INC (VMD). This can be considered as Fairly Valued.
Can you provide the profitability details for VIEMED HEALTHCARE INC?
VIEMED HEALTHCARE INC (VMD) has a profitability rating of 6 / 10.
What is the earnings growth outlook for VIEMED HEALTHCARE INC?
The Earnings per Share (EPS) of VIEMED HEALTHCARE INC (VMD) is expected to grow by 31.06% in the next year.